← Back to headlines
Chemomab, Dogwood Therapeutics Announce GAAP EPS
Chemomab Therapeutics reported a GAAP EPS of $0.00, while Dogwood Therapeutics announced a GAAP EPS of -$0.15.
14 May, 18:33 — 14 May, 18:33
Sources
Showing 1 of 1 sources
Chemomab Therapeutics reported a GAAP EPS of $0.00, while Dogwood Therapeutics announced a GAAP EPS of -$0.15.
